Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 14/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 14/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 14/20 | 0.41 |
| ▸ | TSHR | P16473 | 12/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 12/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 8/20 | 0.41 |
| ▸ | USP2 | O75604 | 6/20 | 0.41 |
| ▸ | PDE9A | O76083 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30813459 | 1.00 | EGFR (0.42) | EGFRCYP1A2CYP3A4CYP2C19TSHR | |
| SCHEMBL27217623 | 0.95 | CYP1A2 (0.42) | CYP1A2CYP3A4CYP2C19TSHRCYP2D6 | |
| SCHEMBL30813410 | 0.95 | CYP1A2 (0.42) | CYP1A2CYP3A4CYP2C19TSHRCYP2D6 | |
| SCHEMBL27217653 | 0.90 | CYP1A2 (0.43) | CYP1A2CYP3A4CYP2C19TSHRCYP2D6 | |
| SCHEMBL30813513 | 0.90 | CYP1A2 (0.43) | CYP1A2CYP3A4CYP2C19TSHRCYP2D6 | |
| SCHEMBL27217888 | 0.89 | CYP1A2 (0.45) | CYP1A2CYP3A4CYP2C19TSHRCYP2D6 | |
| SCHEMBL27217947 | 0.89 | EGFR (0.43) | EGFRCYP1A2CYP3A4CYP2C19TSHR | |
| SCHEMBL30813623 | 0.89 | EGFR (0.43) | EGFRCYP1A2CYP3A4CYP2C19TSHR | |
| SCHEMBL30813667 | 0.85 | CYP1A2 (0.42) | EGFRCYP1A2CYP3A4CYP2C19TSHR | |
| SCHEMBL27217936 | 0.85 | CYP1A2 (0.42) | EGFRCYP1A2CYP3A4CYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158394-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. | 2024-05-16 | — | — | US | disclosed |
| WO-2024059200-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158394-A1 | NEK7 INHIBITORS | NEK7, NEK5, NEK1 | EGFR 4857/4885CYP1A2 4011/4885CYP3A4 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.